Lung Diseases, Obstructive

• GSK Investigational Site — Sofia, Bulgaria
• GSK Investigational Site — Hamburg, Free and Hanseatic City of Hamburg, Germany
• GSK Investigational Site — Frankfurt am Main, Hesse, Germany
• GSK Investigational Site — Hanover, Lower Saxony, Germany

• Altana Pharma/Nycomed — Kolding, Denmark

• Altana Pharma/Nycomed — Busan, South Korea
• Altana Pharma/Nycomed — Daegu, South Korea
• Altana Pharma/Nycomed — Daegu, South Korea
• Altana Pharma/Nycomed — Daejeon, South Korea

• Department of Internal Medicine, Pneumonology and Allergology, Medical University of Warsaw — Warsaw, Poland

• Altana Pharma/Nycomed — Kota Bharu / Kelantan, Malaysia
• Altana Pharma/Nycomed — Kuala Lumpur, Malaysia
• Altana Pharma/Nycomed — Kuala Lumpur, Malaysia
• Altana Pharma/Nycomed — Kuala Lumpur, Malaysia

• Altana Pharma/Nycomed — La Malbaie, Quebec, Canada
• Altana Pharma/Nycomed — London, Canada
• Altana Pharma/Nycomed — London,ON, Canada
• Altana Pharma/Nycomed — Mississauga, Canada

• Altana Pharma/Nycomed — Adelaide South Australia, Australia
• Altana Pharma/Nycomed — Auchenflower, Australia
• Altana Pharma/Nycomed — Bracken Ridge, Australia
• Altana Pharma/Nycomed — Burwood, Australia

• ALTANA Pharma — Cities in Australia, Australia
• ALTANA Pharma — Cities in Austria, Austria
• ALTANA Pharma — Cities in Canada, Canada
• ALTANA Pharma — Cities in France, France

• University of California, San Francisco, Adult — San Francisco, California, United States
• National Jewish Health — Denver, Colorado, United States
• Northwestern Memorial Hospital — Chicago, Illinois, United States
• Brigham & Women's Hospital — Boston, Massachusetts, United States

Not specified